文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

小分子 3PO 抑制糖酵解,但不与 6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶-3(PFKFB3)结合。

Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).

机构信息

Laboratory of Physiopharmacology, University of Antwerp, Belgium.

Laboratory of Medical Biochemistry, University of Antwerp, Belgium.

出版信息

FEBS Lett. 2020 Sep;594(18):3067-3075. doi: 10.1002/1873-3468.13878. Epub 2020 Jul 20.


DOI:10.1002/1873-3468.13878
PMID:32620030
Abstract

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 (PFKFB3) is a key enzyme of the glycolytic pathway, and it plays an essential role in angiogenesis. 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) is frequently used as a glycolysis inhibitor and is thought to inhibit PFKFB3. However, this latter effect of 3PO has never been investigated in detail and was the aim of the present study. To demonstrate binding of 3PO to PFKFB3, we used isothermal titration calorimetry. However, 3PO did not bind to PFKFB3, even up to 750 µm, in contrast to 3 µm of AZ67, which is a potent and specific PFKFB3 inhibitor. Instead, 3PO accumulated lactic acid inside the cells, leading to a decrease in the intracellular pH and an inhibition of enzymatic reactions of the glycolytic pathway.

摘要

6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶同工酶 3(PFKFB3)是糖酵解途径的关键酶,它在血管生成中起着至关重要的作用。3-(3-吡啶基)-1-(4-吡啶基)-2-丙烯-1-酮(3PO)常被用作糖酵解抑制剂,被认为可以抑制 PFKFB3。然而,3PO 对 PFKFB3 的这种抑制作用从未被详细研究过,这是本研究的目的。为了证明 3PO 与 PFKFB3 的结合,我们使用了等温滴定量热法。然而,3PO 甚至在高达 750µm 的浓度下也没有与 PFKFB3 结合,而 3µm 的 AZ67 是一种有效的、特异性的 PFKFB3 抑制剂。相反,3PO 在细胞内积累乳酸,导致细胞内 pH 值下降,并抑制糖酵解途径的酶促反应。

相似文献

[1]
Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).

FEBS Lett. 2020-9

[2]
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.

Mol Cancer Ther. 2008-1

[3]
3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3.

PLoS One. 2020-3-4

[4]
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.

J Transl Med. 2012-5-16

[5]
The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.

Int J Mol Sci. 2021-5-31

[6]
CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.

Gastroenterology. 2020-7

[7]
Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.

Cell Metab. 2013-12-12

[8]
PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.

Toxicol Appl Pharmacol. 2019-2-15

[9]
Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.

J Cell Biochem. 2023-9

[10]
3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells.

Anticancer Res. 2020-5

引用本文的文献

[1]
Metabolic adaptation to acute metabolic stress via PFKFB3 upregulation in rodent beta cells.

Front Endocrinol (Lausanne). 2025-6-17

[2]
Angiogenesis within atherosclerotic plaques: Mechanical regulation, molecular mechanism and clinical diagnosis.

Mechanobiol Med. 2025-2-1

[3]
Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications.

Int J Nanomedicine. 2025-4-5

[4]
Glycometabolic Regulation of Angiogenesis: Mechanisms and Therapeutic Strategies.

Int J Mol Sci. 2025-3-7

[5]
The small molecule inhibitor 3PO is a modulator of neutrophil metabolism, ROS production, and NET release.

Clin Exp Immunol. 2025-1-21

[6]
Pathogenic role of PFKFB3 in endothelial inflammatory diseases.

Front Mol Biosci. 2024-9-10

[7]
Altered metabolism in cancer: insights into energy pathways and therapeutic targets.

Mol Cancer. 2024-9-18

[8]
The Impact of Glycolysis and Its Inhibitors on the Immune Response to Inflammation and Autoimmunity.

Molecules. 2024-3-14

[9]
PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies.

Cell Biosci. 2024-2-10

[10]
Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases.

Int J Mol Sci. 2023-9-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索